Peregrine Pharmaceuticals (NASDAQ:PPHM)
CAPS Rating:
A biopharmaceutical company with a portfolio of clinical stage and pre-clinical product candidates using monoclonal antibodies for the treatment of cancer and viral diseases.
RSS Headlines
Fool UK
Recs
thank you very much, I believe I snagged the high of the year with this dog. it is a testament to my dogged determination in trying to game this anything but intuitive CAPS system! as they say...look out below...I spotted a negative divergence on all of the MACD lighting and a RSI indicator that just flipped upside down. It is also falling under double DOJI patterns every 30 seconds. Did you see that skeedaddy?